Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aceclofenac for IANB Efficacy in Symptomatic Irreversible Pulpitis
NCT03146481Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jul 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in irreversible pulpitis comparing Aceclofenac Arm with Placebo Arm (2 arms). Primary endpoint: Anesthetic success. Started Jul 2016; status: completed.
02
Drugs
aceclofenac
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT03146481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03146481.